FDA drafts guidance on essential outputs for drug delivery devices
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)Clinical TrialsCombination productsCombination products/companion diagnosticsGuidancePerformance evaluationRegulatory Intelligence/PolicyUnited States